Comparing the Two: GLP-1 Medications vs Bariatric Surgery Both GLP-1 therapies and bariatric surgery contribute to weight reduction, but they operate through very different mechanisms and produce distinctly different long-term outcomes
The Multi-Indication Valuation Challenge Here's the governance problem retatrutide makes explicit: How do you value a therapy that bends cost curves across five specialties at onceand over a multi-year horizon
A lot of people in this group are already taking hormones, either oral contraceptives or MHT, and they may elect to stay away from additional hormonal-type treatments, like the antiandrogens spironolactone and finasteride/dutasteride
If you suspect you have a hormonal imbalance, speak to your doctor about appropriate testing and treatment
Nature reviews Molecular cell biology , 22 (2), 142-158
Beyond individual trials, a 2025 meta-analysis covering over 140,000 participants found tirzepatide yields a mean 4.23% greater weight loss than semaglutide (95% CI: 3.22 5.25